FDA advisers recommend 2nd coronavirus vaccine, with agency approval expected soon
A government advisory panel endorsed a second COVID-19 vaccine Thursday, paving the way for the shot to be added to the U.S. vaccination campaign.
Frontline health workers nationwide get first COVID-19 shots as US death toll tops 300,000
Hope among health workers is tempered by grief and the sheer exhaustion of months spent battling a virus that is still surging in the U.S. and around the world.
Watch live: FDA advisory panel meets to review Pfizer vaccine for distribution
Pfizer’s COVID-19 vaccine faces one final hurdle as it races to become the first shot greenlighted in the U.S.: a panel of experts who will scrutinize the company’s data for any red flags.
Pfizer vaccine moves closer to getting the OK in the US
Documents released by U.S. regulators Tuesday confirmed that Pfizer’s vaccine was strongly protective against COVID-19 and appeared safe.
Britain authorizes Pfizer coronavirus vaccine for emergency use
The move makes Britain one of the first countries to begin vaccinating its population as it tries to curb Europe’s deadliest COVID-19 outbreak.
Moderna seeks US, European OK for emergency use of its coronavirus vaccine
The company created its shots with the U.S. National Institutes of Health and said it got the final needed results over the weekend that suggest the vaccine is more than 94% effective.
Pfizer and German partner BioNTech seek emergency use of COVID-19 vaccine in US
The request starts the clock on a process that could bring limited first shots as early as next month and eventually an end to the pandemic -- but not until after a long, hard winter.
Another coronavirus vaccine shows over 90% effectiveness in early analysis
Moderna said its vaccine appears to be 94.5% effective, according to preliminary data from an ongoing U.S. study.
Preliminary data shows Pfizer coronavirus vaccine may be 90% effective
Monday’s announcement does not mean a vaccine is imminent.
US health officials insist no corners cut as study of first single-shot coronavirus vaccine begins
Officials sought Wednesday to assure a skeptical Congress and public that they can trust any shots the government ultimately approves.
Halted study explains just how unlikely we are to get a vaccine by Nov. 3
AstraZeneca has put on hold studies of its vaccine candidate in the U.S. and other countries while it investigates whether a British volunteer’s illness is a side effect or a coincidence.
Major COVID-19 vaccine studies paused after participant grows ill
The pause shows there will be “no compromises” on safety in developing the vaccines, the chief of the National Institutes of Health told Congress on Wednesday.